6.83 USD
↘ 0.36 (5.01%)AT CLOSE (03:59 PM EDT)
Achieve Life Sciences, Inc.
ACHVNASDAQ • USD
6.83
↗ 0.00 (0.00%)
POST MARKET (AS OF 05:32 PM EDT)
Post Market
AS OF 05:32 PM EDT
6.83
↗ 0.00 (0.00%)
Market: OPEN
Achieve Life Sciences, Inc. (ACHV) is currently trading at $6.83. Technicals currently rate "Neutral" while our fundamental analysis reads "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (777.1%) and a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Oct 30, 2026.
Open?$7.12
High?$7.29
Low?$6.57
Prev. Close?$7.19
Volume?1.4M
Avg. Volume?1.4M
VWAP?$6.78
Rel. Volume?0.98x
Bid / Ask
Bid?$5.75 × 100
Ask?$7.71 × 100
Spread?$1.96
Midpoint?$6.73
Valuation & Ratios
Market Cap?741.3M
Shares Out?102.9M
Float?63.4M
Float %?61.6%
P/E Ratio?N/A
P/B Ratio?-50.51
EPS?-$1.11
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Achieve Life Sciences Inc is a late-stage specialty pharmaceutical company focused on the world-wide development and commercialization of cytisinicline as a treatment for nicotine dependence. Its New Drug Application (NDA) for cytisinicline for smoking cessation in adults is supported by two completed Phase 3 studies and an open-label long-term safety study. It has also completed a Phase 2 study of cytisinicline in nicotine e-cigarette cessation, conducted an end-of-Phase 2 meeting with the FDA, and has received Breakthrough Therapy designation for the vaping cessation indication.
Employees
28
Market Cap
741.3M
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Website
Listed
1995-10-12
Address
22722 29TH DR. SE
SEATTLE, WA 98021
Phone: 425-686-1500
SEATTLE, WA 98021
Phone: 425-686-1500
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?10
Piotroski F-Score?0/9Weak
Altman Z-Score?-1.45Distress
Confidence?49%Low
Short InterestSqueeze Risk
Short % of Float?28.10%Squeeze Risk
Short Interest?17.8M
Days to Cover?13.9
Free Float63.4M
Avg Daily Volume1.3M
Settlement Date2026-10-15
Financial Health
Current Ratio?0.95Weak
Quick Ratio?0.95Weak
Cash Ratio?0.24Low
Debt/Equity?-1.02Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-50.51CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-12.2CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?777.1%STRONG▾
Peers50
S&P97
ROA?-59.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-47036000
Enterprise Value?$708.3M
Fundamentals ratios updated end of day